APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cough Lozenges

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cough Lozenges Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchCough Lozenges Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Cough Lozenges Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Cough Lozenges Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cough Lozenges Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Cough Lozenges Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Cough Lozenges market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cough Lozenges include Xi'an Keli Pharmaceutical, Sanofi, Novartis, Mylan, Jiuzhitang, Jiangxi Jianglai Health Technology, Pfizer, Hebei Bianque Pharmaceutical and Guizhou Kehui Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cough Lozenges market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cough Lozenges and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cough Lozenges sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cough Lozenges market size, projected growth trends, production technologies, key applications, and end-use industries.

Cough Lozenges Segment by Company

Xi'an Keli Pharmaceutical

Sanofi

Novartis

Mylan

Jiuzhitang

Jiangxi Jianglai Health Technology

Pfizer

Hebei Bianque Pharmaceutical

Guizhou Kehui Pharmaceutical

GlaxoSmithKline

Bayer

Amgen

AbbVie

AstraZeneca

Reckitt Benckiser

Procter And Gamble

Johnson And Johnson

Herbalife

Cigna

Boehringer Ingelheim

Cough Lozenges Segment by Type

Traditional Chinese Medicine Type

Biological Agent Type

Chemical Medicine Type

Compound Preparation Type

Cough Lozenges Segment by Application

Clinic

Hospital

Pharmacy

Retail Store

Others

Cough Lozenges Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cough Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cough Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cough Lozenges.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cough Lozenges market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cough Lozenges manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cough Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cough Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cough Lozenges Industry Trends Table 2. Cough Lozenges Industry Drivers Table 3. Cough Lozenges Industry Opportunities and Challenges Table 4. Cough Lozenges Industry Restraints Table 5. Global Cough Lozenges Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cough Lozenges Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cough Lozenges Sales by Manufacturers (units) & (2021-2026) Table 8. Global Cough Lozenges Sales Market Share by Manufacturers Table 9. Global Cough Lozenges Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Cough Lozenges Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cough Lozenges Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cough Lozenges Manufacturers, Product Type & Application Table 13. Global Cough Lozenges Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cough Lozenges by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Traditional Chinese Medicine Type Table 17. Major Manufacturers of Biological Agent Type Table 18. Major Manufacturers of Chemical Medicine Type Table 19. Major Manufacturers of Compound Preparation Type Table 20. Global Cough Lozenges Sales by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Cough Lozenges Sales by Type (2021-2026) & (units) Table 22. Global Cough Lozenges Sales by Type (2027-2032) & (units) Table 23. Global Cough Lozenges Sales Market Share by Type (2021-2026) Table 24. Global Cough Lozenges Sales Market Share by Type (2027-2032) Table 25. Global Cough Lozenges Revenue by Type 2021 VS 2025 VS 2032 (units) Table 26. Global Cough Lozenges Revenue by Type (2021-2026) & (units) Table 27. Global Cough Lozenges Revenue by Type (2027-2032) & (units) Table 28. Global Cough Lozenges Revenue Market Share by Type (2021-2026) Table 29. Global Cough Lozenges Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Pharmacy Table 33. Major Manufacturers of Retail Store Table 34. Major Manufacturers of Others Table 35. Global Cough Lozenges Sales by Application 2021 VS 2025 VS 2032 (units) Table 36. Global Cough Lozenges Sales by Application (2021-2026) & (units) Table 37. Global Cough Lozenges Sales by Application (2027-2032) & (units) Table 38. Global Cough Lozenges Sales Market Share by Application (2021-2026) Table 39. Global Cough Lozenges Sales Market Share by Application (2027-2032) Table 40. Global Cough Lozenges Revenue by Application 2021 VS 2025 VS 2032 (units) Table 41. Global Cough Lozenges Revenue by Application (2021-2026) & (units) Table 42. Global Cough Lozenges Revenue by Application (2027-2032) & (units) Table 43. Global Cough Lozenges Revenue Market Share by Application (2021-2026) Table 44. Global Cough Lozenges Revenue Market Share by Application (2027-2032) Table 45. Global Cough Lozenges Sales by Region: 2021 VS 2025 VS 2032 (units) Table 46. Global Cough Lozenges Sales by Region (2021-2026) & (units) Table 47. Global Cough Lozenges Sales Market Share by Region (2021-2026) Table 48. Global Cough Lozenges Sales Forecasted by Region (2027-2032) & (units) Table 49. Global Cough Lozenges Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 51. North America Cough Lozenges Sales by Country (2021-2026) & (units) Table 52. North America Cough Lozenges Sales by Country (2027-2032) & (units) Table 53. Europe Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 54. Europe Cough Lozenges Sales by Country (2021-2026) & (units) Table 55. Europe Cough Lozenges Sales by Country (2027-2032) & (units) Table 56. Asia Pacific Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 57. Asia Pacific Cough Lozenges Sales by Country (2021-2026) & (units) Table 58. Asia Pacific Cough Lozenges Sales by Country (2027-2032) & (units) Table 59. South America, Middle East and Africa Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 60. South America, Middle East and Africa Cough Lozenges Sales by Country (2021-2026) & (units) Table 61. South America, Middle East and Africa Cough Lozenges Sales by Country (2027-2032) & (units) Table 62. Global Cough Lozenges Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Cough Lozenges Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Cough Lozenges Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Cough Lozenges Revenue Market Share by Region (2021-2026) Table 66. Global Cough Lozenges Revenue Market Share by Region (2027-2032) Table 67. Xi'an Keli Pharmaceutical Company Information Table 68. Xi'an Keli Pharmaceutical Business Overview Table 69. Xi'an Keli Pharmaceutical Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Xi'an Keli Pharmaceutical Cough Lozenges Product Portfolio Table 71. Xi'an Keli Pharmaceutical Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi Cough Lozenges Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Cough Lozenges Product Portfolio Table 81. Novartis Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Cough Lozenges Product Portfolio Table 86. Mylan Recent Development Table 87. Jiuzhitang Company Information Table 88. Jiuzhitang Business Overview Table 89. Jiuzhitang Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Jiuzhitang Cough Lozenges Product Portfolio Table 91. Jiuzhitang Recent Development Table 92. Jiangxi Jianglai Health Technology Company Information Table 93. Jiangxi Jianglai Health Technology Business Overview Table 94. Jiangxi Jianglai Health Technology Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Jiangxi Jianglai Health Technology Cough Lozenges Product Portfolio Table 96. Jiangxi Jianglai Health Technology Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Pfizer Cough Lozenges Product Portfolio Table 101. Pfizer Recent Development Table 102. Hebei Bianque Pharmaceutical Company Information Table 103. Hebei Bianque Pharmaceutical Business Overview Table 104. Hebei Bianque Pharmaceutical Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Hebei Bianque Pharmaceutical Cough Lozenges Product Portfolio Table 106. Hebei Bianque Pharmaceutical Recent Development Table 107. Guizhou Kehui Pharmaceutical Company Information Table 108. Guizhou Kehui Pharmaceutical Business Overview Table 109. Guizhou Kehui Pharmaceutical Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Guizhou Kehui Pharmaceutical Cough Lozenges Product Portfolio Table 111. Guizhou Kehui Pharmaceutical Recent Development Table 112. GlaxoSmithKline Company Information Table 113. GlaxoSmithKline Business Overview Table 114. GlaxoSmithKline Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. GlaxoSmithKline Cough Lozenges Product Portfolio Table 116. GlaxoSmithKline Recent Development Table 117. Bayer Company Information Table 118. Bayer Business Overview Table 119. Bayer Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Bayer Cough Lozenges Product Portfolio Table 121. Bayer Recent Development Table 122. Amgen Company Information Table 123. Amgen Business Overview Table 124. Amgen Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Amgen Cough Lozenges Product Portfolio Table 126. Amgen Recent Development Table 127. AbbVie Company Information Table 128. AbbVie Business Overview Table 129. AbbVie Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. AbbVie Cough Lozenges Product Portfolio Table 131. AbbVie Recent Development Table 132. AstraZeneca Company Information Table 133. AstraZeneca Business Overview Table 134. AstraZeneca Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. AstraZeneca Cough Lozenges Product Portfolio Table 136. AstraZeneca Recent Development Table 137. Reckitt Benckiser Company Information Table 138. Reckitt Benckiser Business Overview Table 139. Reckitt Benckiser Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Reckitt Benckiser Cough Lozenges Product Portfolio Table 141. Reckitt Benckiser Recent Development Table 142. Procter And Gamble Company Information Table 143. Procter And Gamble Business Overview Table 144. Procter And Gamble Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Procter And Gamble Cough Lozenges Product Portfolio Table 146. Procter And Gamble Recent Development Table 147. Johnson And Johnson Company Information Table 148. Johnson And Johnson Business Overview Table 149. Johnson And Johnson Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Johnson And Johnson Cough Lozenges Product Portfolio Table 151. Johnson And Johnson Recent Development Table 152. Herbalife Company Information Table 153. Herbalife Business Overview Table 154. Herbalife Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Herbalife Cough Lozenges Product Portfolio Table 156. Herbalife Recent Development Table 157. Cigna Company Information Table 158. Cigna Business Overview Table 159. Cigna Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Cigna Cough Lozenges Product Portfolio Table 161. Cigna Recent Development Table 162. Boehringer Ingelheim Company Information Table 163. Boehringer Ingelheim Business Overview Table 164. Boehringer Ingelheim Cough Lozenges Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Boehringer Ingelheim Cough Lozenges Product Portfolio Table 166. Boehringer Ingelheim Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Cough Lozenges Distributors List Table 170. Cough Lozenges Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Cough Lozenges Product Image Figure 2. Global Cough Lozenges Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cough Lozenges Market Size (2021-2032) & (US$ Million) Figure 4. Global Cough Lozenges Sales (2021-2032) & (units) Figure 5. Global Cough Lozenges Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cough Lozenges Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Traditional Chinese Medicine Type Image Figure 9. Biological Agent Type Image Figure 10. Chemical Medicine Type Image Figure 11. Compound Preparation Type Image Figure 12. Global Cough Lozenges Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Cough Lozenges Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Cough Lozenges Sales Market Share by Type (2021-2032) Figure 15. Global Cough Lozenges Revenue by Type (2021 VS 2025 VS 2032) & (units) Figure 16. Global Cough Lozenges Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cough Lozenges Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Pharmacy Image Figure 21. Retail Store Image Figure 22. Others Image Figure 23. Global Cough Lozenges Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 24. Global Cough Lozenges Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cough Lozenges Sales Market Share by Application (2021-2032) Figure 26. Global Cough Lozenges Revenue by Application (2021 VS 2025 VS 2032) & (units) Figure 27. Global Cough Lozenges Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Cough Lozenges Revenue Market Share by Application (2021-2032) Figure 29. North America Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 30. North America Cough Lozenges Sales Market Share by Country (2021-2032) Figure 31. U.S. Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 32. Canada Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 33. Mexico Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 34. Europe Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 35. Europe Cough Lozenges Sales Market Share by Country (2021-2032) Figure 36. Germany Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 37. France Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 38. U.K. Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 39. Italy Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 40. Netherlands Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 41. Asia Pacific Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 42. Asia Pacific Cough Lozenges Sales Market Share by Country (2021-2032) Figure 43. China Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 44. Japan Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 45. South Korea Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 46. Southeast Asia Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 47. India Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 48. Australia Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 49. South America, Middle East and Africa Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 50. South America, Middle East and Africa Cough Lozenges Sales Market Share by Country (2021-2032) Figure 51. Brazil Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 52. South Africa Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 53. Saudi Arabia Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 54. Turkey Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 55. Argentina Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 56. UAE Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 57. Egypt Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 58. Chile Cough Lozenges Sales and Growth Rate (2021-2032) & (units) Figure 59. Global Cough Lozenges Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Cough Lozenges Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Cough Lozenges Revenue (2021-2032) & (US$ Million) Figure 62. North America Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Cough Lozenges Revenue (2021-2032) & (US$ Million) Figure 64. Europe Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Cough Lozenges Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Cough Lozenges Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Cough Lozenges Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Cough Lozenges Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Chinese Medicine Type
  • Biological Agent Type
  • Chemical Medicine Type
  • Compound Preparation Type
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Retail Store
  • Others
Companies covered
  • Xi'an Keli Pharmaceutical
  • Sanofi
  • Novartis
  • Mylan
  • Jiuzhitang
  • Jiangxi Jianglai Health Technology
  • Pfizer
  • Hebei Bianque Pharmaceutical
  • Guizhou Kehui Pharmaceutical
  • GlaxoSmithKline
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Reckitt Benckiser
  • Procter And Gamble
  • Johnson And Johnson
  • Herbalife
  • Cigna
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cough Lozenges Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cough Lozenges Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cough Lozenges Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cough Lozenges Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cough Lozenges Market Dynamics
  1. 2.1 Cough Lozenges Industry Trends
  2. 2.2 Cough Lozenges Industry Drivers
  3. 2.3 Cough Lozenges Industry Opportunities and Challenges
  4. 2.4 Cough Lozenges Industry Restraints
3 Cough Lozenges Market by Manufacturers
  1. 3.1 Global Cough Lozenges Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cough Lozenges Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cough Lozenges Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cough Lozenges Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cough Lozenges Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cough Lozenges Manufacturers, Product Type & Application
  7. 3.7 Global Cough Lozenges Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cough Lozenges Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cough Lozenges Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cough Lozenges Tier 1, Tier 2, and Tier 3
4 Cough Lozenges Market by Type
  1. 4.1 Cough Lozenges Type Introduction
  2. 4.1.1 Traditional Chinese Medicine Type
  3. 4.1.2 Biological Agent Type
  4. 4.1.3 Chemical Medicine Type
  5. 4.1.4 Compound Preparation Type
  6. 4.2 Global Cough Lozenges Sales by Type
  7. 4.2.1 Global Cough Lozenges Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cough Lozenges Sales by Type (2021-2032)
  9. 4.2.3 Global Cough Lozenges Sales Market Share by Type (2021-2032)
  10. 4.3 Global Cough Lozenges Revenue by Type
  11. 4.3.1 Global Cough Lozenges Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cough Lozenges Revenue by Type (2021-2032)
  13. 4.3.3 Global Cough Lozenges Revenue Market Share by Type (2021-2032)
5 Cough Lozenges Market by Application
  1. 5.1 Cough Lozenges Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Retail Store
  6. 5.1.5 Others
  7. 5.2 Global Cough Lozenges Sales by Application
  8. 5.2.1 Global Cough Lozenges Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cough Lozenges Sales by Application (2021-2032)
  10. 5.2.3 Global Cough Lozenges Sales Market Share by Application (2021-2032)
  11. 5.3 Global Cough Lozenges Revenue by Application
  12. 5.3.1 Global Cough Lozenges Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cough Lozenges Revenue by Application (2021-2032)
  14. 5.3.3 Global Cough Lozenges Revenue Market Share by Application (2021-2032)
6 Global Cough Lozenges Sales by Region
  1. 6.1 Global Cough Lozenges Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cough Lozenges Sales by Region (2021-2032)
  3. 6.2.1 Global Cough Lozenges Sales by Region (2021-2026)
  4. 6.2.2 Global Cough Lozenges Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cough Lozenges Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cough Lozenges Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cough Lozenges Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cough Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cough Lozenges Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cough Lozenges Revenue by Region
  1. 7.1 Global Cough Lozenges Revenue by Region
  2. 7.1.1 Global Cough Lozenges Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cough Lozenges Revenue by Region (2021-2026)
  4. 7.1.3 Global Cough Lozenges Revenue by Region (2027-2032)
  5. 7.1.4 Global Cough Lozenges Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cough Lozenges Revenue (2021-2032)
  8. 7.2.2 North America Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cough Lozenges Revenue (2021-2032)
  11. 7.3.2 Europe Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cough Lozenges Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cough Lozenges Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cough Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi'an Keli Pharmaceutical
  2. 8.1.1 Xi'an Keli Pharmaceutical Company Information
  3. 8.1.2 Xi'an Keli Pharmaceutical Business Overview
  4. 8.1.3 Xi'an Keli Pharmaceutical Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xi'an Keli Pharmaceutical Cough Lozenges Product Portfolio
  6. 8.1.5 Xi'an Keli Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Cough Lozenges Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Cough Lozenges Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Cough Lozenges Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Jiuzhitang
  26. 8.5.1 Jiuzhitang Company Information
  27. 8.5.2 Jiuzhitang Business Overview
  28. 8.5.3 Jiuzhitang Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiuzhitang Cough Lozenges Product Portfolio
  30. 8.5.5 Jiuzhitang Recent Developments
  31. 8.6 Jiangxi Jianglai Health Technology
  32. 8.6.1 Jiangxi Jianglai Health Technology Company Information
  33. 8.6.2 Jiangxi Jianglai Health Technology Business Overview
  34. 8.6.3 Jiangxi Jianglai Health Technology Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Jianglai Health Technology Cough Lozenges Product Portfolio
  36. 8.6.5 Jiangxi Jianglai Health Technology Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Cough Lozenges Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Hebei Bianque Pharmaceutical
  44. 8.8.1 Hebei Bianque Pharmaceutical Company Information
  45. 8.8.2 Hebei Bianque Pharmaceutical Business Overview
  46. 8.8.3 Hebei Bianque Pharmaceutical Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hebei Bianque Pharmaceutical Cough Lozenges Product Portfolio
  48. 8.8.5 Hebei Bianque Pharmaceutical Recent Developments
  49. 8.9 Guizhou Kehui Pharmaceutical
  50. 8.9.1 Guizhou Kehui Pharmaceutical Company Information
  51. 8.9.2 Guizhou Kehui Pharmaceutical Business Overview
  52. 8.9.3 Guizhou Kehui Pharmaceutical Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Guizhou Kehui Pharmaceutical Cough Lozenges Product Portfolio
  54. 8.9.5 Guizhou Kehui Pharmaceutical Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Cough Lozenges Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Cough Lozenges Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 Amgen
  68. 8.12.1 Amgen Company Information
  69. 8.12.2 Amgen Business Overview
  70. 8.12.3 Amgen Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Amgen Cough Lozenges Product Portfolio
  72. 8.12.5 Amgen Recent Developments
  73. 8.13 AbbVie
  74. 8.13.1 AbbVie Company Information
  75. 8.13.2 AbbVie Business Overview
  76. 8.13.3 AbbVie Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AbbVie Cough Lozenges Product Portfolio
  78. 8.13.5 AbbVie Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Cough Lozenges Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
  85. 8.15 Reckitt Benckiser
  86. 8.15.1 Reckitt Benckiser Company Information
  87. 8.15.2 Reckitt Benckiser Business Overview
  88. 8.15.3 Reckitt Benckiser Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Reckitt Benckiser Cough Lozenges Product Portfolio
  90. 8.15.5 Reckitt Benckiser Recent Developments
  91. 8.16 Procter And Gamble
  92. 8.16.1 Procter And Gamble Company Information
  93. 8.16.2 Procter And Gamble Business Overview
  94. 8.16.3 Procter And Gamble Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Procter And Gamble Cough Lozenges Product Portfolio
  96. 8.16.5 Procter And Gamble Recent Developments
  97. 8.17 Johnson And Johnson
  98. 8.17.1 Johnson And Johnson Company Information
  99. 8.17.2 Johnson And Johnson Business Overview
  100. 8.17.3 Johnson And Johnson Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Johnson And Johnson Cough Lozenges Product Portfolio
  102. 8.17.5 Johnson And Johnson Recent Developments
  103. 8.18 Herbalife
  104. 8.18.1 Herbalife Company Information
  105. 8.18.2 Herbalife Business Overview
  106. 8.18.3 Herbalife Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Herbalife Cough Lozenges Product Portfolio
  108. 8.18.5 Herbalife Recent Developments
  109. 8.19 Cigna
  110. 8.19.1 Cigna Company Information
  111. 8.19.2 Cigna Business Overview
  112. 8.19.3 Cigna Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cigna Cough Lozenges Product Portfolio
  114. 8.19.5 Cigna Recent Developments
  115. 8.20 Boehringer Ingelheim
  116. 8.20.1 Boehringer Ingelheim Company Information
  117. 8.20.2 Boehringer Ingelheim Business Overview
  118. 8.20.3 Boehringer Ingelheim Cough Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Boehringer Ingelheim Cough Lozenges Product Portfolio
  120. 8.20.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cough Lozenges Value Chain Analysis
  2. 9.1.1 Cough Lozenges Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cough Lozenges Production Mode & Process
  6. 9.2 Cough Lozenges Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cough Lozenges Distributors
  9. 9.2.3 Cough Lozenges Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst